What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Immune system
The scientist’s investigation covers issues in CD38, Cell biology, Receptor, Signal transduction and Immunology.
His CD38 research incorporates elements of Molecular biology, CD31, Biochemistry and Chronic lymphocytic leukemia.
His work carried out in the field of Chronic lymphocytic leukemia brings together such families of science as Cancer research, Stromal cell and Chemotaxis.
His research on Cell biology also deals with topics like
- CD3 and related T-cell receptor,
- Jurkat cells together with Cytokine.
His biological study spans a wide range of topics, including Regulation of gene expression, Cell adhesion, Cell adhesion molecule and Plasma protein binding.
His Signal transduction research is multidisciplinary, relying on both Natural killer cell, Cell growth, Phosphorylation and CD19.
His most cited work include:
- Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology (539 citations)
- The release of platelet-activating factor from human endothelial cells in culture. (377 citations)
- Human CD38 (ADP-Ribosyl Cyclase) Is a Counter-Receptor of CD31, an Ig Superfamily Member (315 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns CD38, Immunology, Molecular biology, Monoclonal antibody and Cancer research.
The concepts of his CD38 study are interwoven with issues in Receptor, Immune system, Signal transduction and Chronic lymphocytic leukemia.
His Immunology study combines topics from a wide range of disciplines, such as Cell surface receptor and Internal medicine.
His study looks at the intersection of Molecular biology and topics like Antigen with Cytotoxic T cell.
His Monoclonal antibody study integrates concerns from other disciplines, such as Epitope, Human leukocyte antigen, In vivo and Virology.
Fabio Malavasi has researched Cancer research in several fields, including Daratumumab, Bone marrow, Multiple myeloma and Immunotherapy.
He most often published in these fields:
- CD38 (36.60%)
- Immunology (27.06%)
- Molecular biology (27.06%)
What were the highlights of his more recent work (between 2011-2021)?
- Cancer research (23.20%)
- CD38 (36.60%)
- Immunology (27.06%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, CD38, Immunology, Immune system and Monoclonal antibody.
Fabio Malavasi interconnects Chronic lymphocytic leukemia, Daratumumab, Antibody, Bone marrow and Multiple myeloma in the investigation of issues within Cancer research.
His CD38 study results in a more complete grasp of Cell biology.
He works mostly in the field of Immunology, limiting it down to topics relating to In vivo and, in certain cases, Epitope, as a part of the same area of interest.
Fabio Malavasi combines subjects such as Molecular biology, Serology and Antigen with his study of Monoclonal antibody.
He focuses mostly in the field of Molecular biology, narrowing it down to matters related to Cell culture and, in some cases, CD49d.
Between 2011 and 2021, his most popular works were:
- CD38 and CD157: A long journey from activation markers to multifunctional molecules (156 citations)
- CD38 antibodies in multiple myeloma: back to the future. (147 citations)
- Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma (136 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Enzyme
His primary areas of investigation include Immunology, CD38, Cancer research, Immune system and Chronic lymphocytic leukemia.
His Immunology research incorporates elements of Cytotoxic T cell, Internal medicine and In vivo.
His CD38 study is concerned with Cell biology in general.
His Cancer research study combines topics in areas such as Immunohistochemistry, Tumor microenvironment, Flow cytometry, Monoclonal antibody and Immunotherapy.
The various areas that Fabio Malavasi examines in his Immune system study include Mesenchymal stem cell and Antigen.
His studies in Chronic lymphocytic leukemia integrate themes in fields like Cell culture, Cell adhesion, Disease and Cancer immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
